U.S. Food and Drug Administration Approves Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for Treatment of HIV-1 Infection
– In Clinical Trials, Biktarvy Demonstrated High Efficacy, Few Interactions With Other Drugs and a High Barrier to Resistance Through 48 Weeks – FOSTER CITY,...